Source:http://linkedlifedata.com/resource/pubmed/id/18616871
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-7-11
|
pubmed:abstractText |
Approximately half of the patients with essential thrombocythaemia (ET) harbor the JAK2 V617F mutation. Despite a phenotypic mimicry of JAK2 V617F positive ET and polycythaemia vera (PV), the data on thromboembolic risk and correlation to JAK2 mutation status are ambiguous. On a strictly WHO defined ET cohort we evaluated possible clinical correlations to the JAK2 mutation status including a history of previous thrombosis. We used a highly sensitive quantitative real-time PCR (qPCR) assay for JAK2 V617F detection and allele burden quantification in a single institution study of 55 patients. A significantly increased prevalence of arterial thrombosis was recorded in JAK2 positive ET (p=0.001). There was no association between the mutational load and thrombosis. As compared to their JAK2 V617F negative counterparts, the JAK2 V617F positive patients had PV-like biochemical characteristics such as higher haemoglobin levels (p=0.02), lower platelet counts (p=0.002) and lower plasma EPO levels (p=0.04). The JAK2 V617F mutation per se but not the mutational load in patients with ET is associated with a PV-like phenotype and a higher prevalence of previous arterial thrombosis. This study adds further support to the contention of the JAK2 V617F mutation as a marker of increased risk of thrombosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1607-8454
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18616871-Adult,
pubmed-meshheading:18616871-Aged,
pubmed-meshheading:18616871-Aged, 80 and over,
pubmed-meshheading:18616871-Alleles,
pubmed-meshheading:18616871-Cohort Studies,
pubmed-meshheading:18616871-Female,
pubmed-meshheading:18616871-Humans,
pubmed-meshheading:18616871-Janus Kinase 2,
pubmed-meshheading:18616871-Male,
pubmed-meshheading:18616871-Middle Aged,
pubmed-meshheading:18616871-Mutation, Missense,
pubmed-meshheading:18616871-Phenotype,
pubmed-meshheading:18616871-Polycythemia Vera,
pubmed-meshheading:18616871-Polymerase Chain Reaction,
pubmed-meshheading:18616871-Prevalence,
pubmed-meshheading:18616871-Thrombocythemia, Essential,
pubmed-meshheading:18616871-Thrombosis
|
pubmed:year |
2008
|
pubmed:articleTitle |
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden.
|
pubmed:affiliation |
Department of Haematology, Odense University Hospital, Denmark. thomas.stauffer.larsen@ouh.regionsyddanmark.dk
|
pubmed:publicationType |
Journal Article
|